Research on Biomarkers of Clostridioides Difficile Infection in Inflammatory Bowel Disease Patients Defined by Gut Microbiome and Fecal Metabolomics Alterations

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The goal of this research is to compare alterations of gut microbiota and fecal metabolomics alterations between inflammatory bowel disease patients infected with or without Clostridioides difficile. The main questions it aim to answer are: which bacterial genus or fecal metabolites can discriminate IBD patients infected or more likely to be infected with Clostridioides difficile and their role in the pathogenesis of Clostridioides difficile. type of study: observational study participant population/health conditions 1. population diagnosed with Ulcerative colitis or Crohn's disease 2. Having diarrhea Participants will be included in this research. If there is a comparison group: Researchers will compare healthy people without IBD or any diarrhea to see if disease or diarrhea would affect the gut microbiota and metabolites.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
View:

• inpatients diagnosed with ulcerative colitis or Crohn's disease in Renji hospital

• age from 18 to 75 years old

Locations
Other Locations
China
Shanghai jiaotong university, school of medicine, affliated Renji hospital
RECRUITING
Shanghai
Contact Information
Primary
Yang
15828660135@163.com
13262906006
Time Frame
Start Date: 2022-11-07
Estimated Completion Date: 2024-12-30
Participants
Target number of participants: 100
Treatments
IBD
IBD+CDI
Health control
Sponsors
Leads: RenJi Hospital

This content was sourced from clinicaltrials.gov